Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
No news anytime soon on Sandoz sale, says Novartis
Pharmaforum
Thu, 02/3/22 - 10:35 am
Novartis
Vas Narasimhan
Sandoz
generics
M&A
AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat
Fierce Pharma
Wed, 02/2/22 - 11:50 pm
AbbVie
earnings
Restasis
FDA
generics
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
Fierce Pharma
Wed, 01/26/22 - 11:00 am
AbbVie
antitrust
Bystolic
generics
Allergan
This Week at FDA: Generic drug approvals continue downward trend, new guidance on clinical trial diversity coming
RAPS.org
Fri, 01/21/22 - 11:01 am
FDA
regulatory
clinical trials
clinical trial diversity
generics
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Fierce Pharma
Fri, 01/21/22 - 11:00 am
Viatris
diabetes
Semglee
insulin
generics
27 drugmakers to provide generic COVID drug to low-income countries
Pharmaforum
Thu, 01/20/22 - 11:29 pm
generics
Merck
molnupiravir
COVID-19
antivirals
Mark Cuban's drug company launches online pharmacy
Beckers Hospital Review
Wed, 01/19/22 - 11:07 pm
Mark Cuban
generics
Mark Cuban Cost Plus Drugs
online pharmacies
‘Skinny labels’ on generics can save patients money, research shows, but recent court decisions cloud future
Endpoints
Wed, 01/12/22 - 11:28 pm
generics
skinny labels
Teva and Novartis’ Sandoz launch Narcan generics on same day, brand marketer Emergent remains in play
Endpoints
Wed, 01/5/22 - 10:47 pm
Teva Pharmaceutical
Novartis
Sandoz
generics
Narcan
Emergent BioSolutions
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Reuters
Tue, 01/4/22 - 10:46 pm
Dr Reddy's
Merck
generics
COVID-19
molnupiravir
Novartis blocks generic to MS blockbuster Gilenya in US patent dispute
Pharmaforum
Tue, 01/4/22 - 10:50 am
Novartis
Gilenya
patents
HEC Pharma
generics
multiple sclerosis
MS
Humana, Centene sue drugmakers, alleging anticompetitive practices on HIV drugs
BioPharma Dive
Thu, 12/16/21 - 10:45 am
Humana
Centene
generics
anticompetitive practices
Gilead Sciences
Bristol Myers Squibb
JNJ
Teva Pharmaceuticals
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Viatris
generics
Symbicort
AstraZeneca
patents
COPD
asthma
Novartis petitions FDA to block 18 generic competitors for its megablockbuster heart drug until 2024
Endpoints
Mon, 12/6/21 - 10:52 am
Novartis
generics
Entresto
Sun Pharma yanks thousands of erectile dysfunction tablets after manufacturing mishap
Fierce Pharma
Mon, 11/22/21 - 10:32 am
Sun Pharma
generics
tadalafil
erectile dysfunction
product recalls
Cialis
EQT, Biontech investor family consider Sandoz bid
Yahoo/Reuters
Fri, 11/19/21 - 11:12 am
EQT
BioNTech
Sandoz
generics
Novartis
M&A
CPhI: As Covid-19 restrictions ease, an inspection backlog could have a big effect on new drugs, generics
Endpoints
Thu, 11/11/21 - 11:09 am
CPhI
pandemic
FDA
regulatory
COVID-19
inspections
generics
Swiss socialists say government should buy Sandoz
Pharmaforum
Mon, 11/8/21 - 10:38 am
Switzerland
Novartis
Sandoz
M&A
generics
Novartis looking into future of its Sandoz’ generics business
Pharmaforum
Tue, 10/26/21 - 10:30 am
Novartis
generics
Sandoz
Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill
Stat
Wed, 10/20/21 - 10:07 am
Gates Foundation
generics
COVID-19
antivirals
Merck
molnupiravir
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »